PROCEPT BioRobotics Corporation PRCT Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $322.02M+4.5% | $308.05M+2.7% | $299.91M+9.1% | $274.95M+10.4% | $249.12M+11.0% | ||
| $116.01M+3.7% | $111.83M+5.2% | $106.32M+8.0% | $98.46M+6.0% | $92.9M+6.3% | ||
| $206.01M+5.0% | $196.23M+1.4% | $193.59M+9.7% | $176.49M+13.0% | $156.23M+14.0% | ||
| 64%+0.3pp | 63.7%-0.8pp | 64.5%+0.4pp | 64.2%+1.5pp | 62.7%+1.6pp | ||
| $76.34M+7.1% | $71.28M+5.9% | $67.29M+2.3% | $65.75M+0.2% | $65.62M+5.3% | ||
| $238.7M+4.3% | $228.81M+4.6% | $218.83M+8.1% | $202.51M+8.3% | $187.01M+9.1% | ||
| $315.04M+5.0% | $300.09M+4.9% | $286.11M+6.7% | $268.25M+6.2% | $252.63M+8.1% | ||
| $315.04M+5.0% | $300.09M+4.9% | $286.11M+6.7% | $268.25M+6.2% | $252.63M+8.1% | ||
| -$109.03M-5.0% | -$103.86M-12.2% | -$92.53M-0.8% | -$91.76M+4.8% | -$96.4M+0.2% | ||
| -33.9%-0.1pp | -33.7%-2.9pp | -30.9%+2.5pp | -33.4%+5.3pp | -38.7%+4.3pp | ||
| $3.53M-1.6% | $3.59M-2.0% | $3.66M-5.7% | $3.88M-3.4% | $4.02M-4.0% | ||
| —— | -$157K-33.3% | -$117.75K-50.0% | -$78.5K-100% | -$39.25K— | ||
| —— | —— | —— | —— | -$93.07M-2.2% | ||
| —— | —— | —— | —— | $229K-37.8% | ||
| -$102.47M-7.2% | -$95.57M-13.0% | -$84.58M-0.5% | -$84.15M+6.7% | -$90.19M+1.3% | ||
| -31.8%-0.8pp | -31%-2.8pp | -28.2%+2.4pp | -30.6%+5.6pp | -36.2%+4.5pp | ||
| -$1.82-6.4% | -$1.71-12.5% | -$1.52+1.3% | -$1.54+8.9% | -$1.69+3.4% | ||
| -$1.82-6.4% | -$1.71-12.5% | -$1.52+1.3% | -$1.54+8.9% | -$1.69+3.4% | ||
| 223.2M+0.7% | 221.6M+1.6% | 218.2M+1.7% | 214.5M+1.8% | 210.7M+1.9% | ||
| 223.2M+0.7% | 221.6M+1.6% | 218.2M+1.7% | 214.5M+1.8% | 210.7M+1.9% | ||
| -$102.71M-7.4% | -$95.65M-13.2% | -$84.52M-0.3% | -$84.29M+6.4% | -$90.08M+1.4% | ||
| $10.23M-14.9% | $12.02M+0.7% | $11.93M+0.9% | $11.82M+12.1% | $10.55M+8.1% | ||
| $322.02M+4.5% | $308.05M+2.7% | $299.91M+9.1% | $274.95M+10.4% | $249.12M+11.0% | ||
| -$109.03M-5.0% | -$103.86M-12.2% | -$92.53M-0.8% | -$91.76M+4.8% | -$96.4M+0.2% | ||
| -$102.38M-5.0% | -$97.47M-12.8% | -$86.4M-0.6% | -$85.92M+5.5% | -$90.88M+0.5% | ||
| -$102.38M-5.0% | -$97.47M-12.8% | -$86.4M-0.6% | -$85.92M+5.5% | -$90.88M+0.5% | ||
| -31.8%-0.2pp | -31.6%-2.8pp | -28.8%+2.4pp | -31.2%+5.2pp | -36.5%+4.2pp | ||
| -$109.03M-5.0% | -$103.86M-12.2% | -$92.53M-0.8% | -$91.76M+4.8% | -$96.4M+0.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is PROCEPT BioRobotics Corporation's revenue?
- PROCEPT BioRobotics Corporation (PRCT) generated $322.0M in revenue over the trailing twelve months, up 29.3% year over year.
- Is PROCEPT BioRobotics Corporation profitable?
- PROCEPT BioRobotics Corporation is not currently profitable: it reported a net loss of $102.5M over the trailing twelve months, a -31.8% net margin.
- What are PROCEPT BioRobotics Corporation's profit margins?
- Gross margin is 64.0% and operating margin is -33.9%, with a -31.8% net margin.
- What is PROCEPT BioRobotics Corporation's earnings per share?
- PROCEPT BioRobotics Corporation's diluted EPS over the trailing twelve months is $-1.82.
- Where does PROCEPT BioRobotics Corporation's income statement data come from?
- Every line is extracted from PROCEPT BioRobotics Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
